113 related articles for article (PubMed ID: 9116319)
1. P-glycoprotein: the intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer.
Chung HC; Rha SY; Kim JH; Roh JK; Min JS; Lee KS; Kim BS; Lee KB
Breast Cancer Res Treat; 1997 Jan; 42(1):65-72. PubMed ID: 9116319
[TBL] [Abstract][Full Text] [Related]
2. The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients.
Stamatovic L; Susnjar S; Gavrilovic D; Minic I; Ursulovic T; Dzodic R
J BUON; 2018; 23(5):1273-1280. PubMed ID: 30570847
[TBL] [Abstract][Full Text] [Related]
3. p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer.
Linn SC; Honkoop AH; Hoekman K; van der Valk P; Pinedo HM; Giaccone G
Br J Cancer; 1996 Jul; 74(1):63-8. PubMed ID: 8679460
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
Sergieva SB; Timcheva KV; Hadjiolov ND
J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic effect of Jin Long capsule combined with neoadjuvant chemotherapy on invasive breast cancer and the expression change of multidrug resistance proteins].
Yang TY; Yi W; Wen J; Gan CY; Yang YC; Dai M
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):118-123. PubMed ID: 30862141
[No Abstract] [Full Text] [Related]
6. [Efficacy analysis of THP-containing regimens as neoadjuvant and adjuvant chemotherapy for primary breast cancer].
Wang LZ; Ouyang T; Wang TF; Xie YT; Fan ZQ; Fan T; Lin BY; Li JF
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):143-6. PubMed ID: 22780935
[TBL] [Abstract][Full Text] [Related]
7. c-erbB-2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy.
Vargas-Roig LM; Gago FE; Tello O; Martin de Civetta MT; Ciocca DR
Int J Cancer; 1999 Apr; 84(2):129-34. PubMed ID: 10096243
[TBL] [Abstract][Full Text] [Related]
8. Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP.
Schneider J; Lucas R; Sánchez J; Ruibal A; Tejerina A; Martín M
Anticancer Res; 2000; 20(6B):4373-7. PubMed ID: 11205274
[TBL] [Abstract][Full Text] [Related]
9. Growth fraction as a predictor of response to chemotherapy in node-negative breast cancer.
Aleskandarany MA; Green AR; Rakha EA; Mohammed RA; Elsheikh SE; Powe DG; Paish EC; Macmillan RD; Chan S; Ahmed SI; Ellis IO
Int J Cancer; 2010 Apr; 126(7):1761-9. PubMed ID: 19711345
[TBL] [Abstract][Full Text] [Related]
10. Expression of nuclear factor kappa B (NF-κB) as a predictor of poor pathologic response to chemotherapy in patients with locally advanced breast cancer.
Prajoko YW; Aryandono T
Asian Pac J Cancer Prev; 2014; 15(2):595-8. PubMed ID: 24568463
[TBL] [Abstract][Full Text] [Related]
11. Histologic grade of locally advanced infiltrating ductal carcinoma after treatment with induction chemotherapy.
Frierson HF; Fechner RE
Am J Clin Pathol; 1994 Aug; 102(2):154-7. PubMed ID: 8042581
[TBL] [Abstract][Full Text] [Related]
12. Association of immunohistochemically defined molecular subtypes with clinical response to presurgical chemotherapy in patients with advanced breast cancer.
Khokher S; Qureshi MU; Mahmood S; Nagi AH
Asian Pac J Cancer Prev; 2013; 14(5):3223-8. PubMed ID: 23803108
[TBL] [Abstract][Full Text] [Related]
13. [Influence of P-glycoprotein expression on chemotherapeutic response of metastatic breast carcinoma].
Li EX; Li Y; Yang J; He J; Chen L; Wang JB; Zhou XJ; Li R
Ai Zheng; 2002 Apr; 21(4):430-2. PubMed ID: 12452027
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer.
Honkoop AH; van Diest PJ; de Jong JS; Linn SC; Giaccone G; Hoekman K; Wagstaff J; Pinedo HM
Br J Cancer; 1998 Feb; 77(4):621-6. PubMed ID: 9484820
[TBL] [Abstract][Full Text] [Related]
15. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancer.
Livi L; Saieva C; Borghesi S; De Luca Cardillo C; Scotti V; Mangoni M; Greto D; Cataliotti L; Paiar F; Bianchi S; Biti GP
J Chemother; 2009 Nov; 21(5):558-65. PubMed ID: 19933048
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
Schramm A; Schochter F; Friedl TWP; de Gregorio N; Andergassen U; Alunni-Fabbroni M; Trapp E; Jaeger B; Heinrich G; Camara O; Decker T; Ober A; Mahner S; Fehm TN; Pantel K; Fasching PA; Schneeweiss A; Janni W; Rack BK;
Clin Breast Cancer; 2017 Jul; 17(4):279-285. PubMed ID: 28190761
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer.
Ro J; Sahin A; Ro JY; Fritsche H; Hortobagyi G; Blick M
Hum Pathol; 1990 Aug; 21(8):787-91. PubMed ID: 1974874
[TBL] [Abstract][Full Text] [Related]
19. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.
Calais G; Berger C; Descamps P; Chapet S; Reynaud-Bougnoux A; Body G; Bougnoux P; Lansac J; Le Floch O
Cancer; 1994 Aug; 74(4):1283-8. PubMed ID: 8055449
[TBL] [Abstract][Full Text] [Related]
20. Fluorouracil, doxorubicin, and cyclophosphamide versus fluorouracil, doxorubicin, and cyclophosphamide plus lonidamine for the treatment of advanced breast cancer: a multicentric randomized clinical study.
Calabresi F; Di Lauro L; Marolla P; Curcio CG; Paoletti G; Calabró A; Giannarelli D; Ballatore P; Foggi CM; Di Palma M
Semin Oncol; 1991 Apr; 18(2 Suppl 4):66-72. PubMed ID: 2031201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
